Oncologists' and Cancer Patients' Views on Whole-Exome Sequencing and Incidental Findings: Results from The CanSeq Study

@article{Gray2016OncologistsAC,
  title={Oncologists' and Cancer Patients' Views on Whole-Exome Sequencing and Incidental Findings: Results from The CanSeq Study},
  author={S. Gray and E. Park and J. Najita and Yolanda Martins and L. Traeger and Elizabeth Bair and J. Gagne and J. Garber and P. J{\"a}nne and N. Lindeman and C. Lowenstein and Nelly Oliver and L. Sholl and E. V. Van Allen and N. Wagle and Sam Wood and L. Garraway and S. Joffe},
  journal={Genetics in medicine : official journal of the American College of Medical Genetics},
  year={2016},
  volume={18},
  pages={1011 - 1019}
}
  • S. Gray, E. Park, +15 authors S. Joffe
  • Published 2016
  • Medicine
  • Genetics in medicine : official journal of the American College of Medical Genetics
Purpose:Although targeted sequencing improves outcomes for many cancer patients, it remains uncertain how somatic and germ-line whole-exome sequencing (WES) will integrate into care.Methods:We conducted surveys and interviews within a study of WES integration at an academic center to determine oncologists’ attitudes about WES and to identify lung and colorectal cancer patients’ preferences for learning WES findings.Results:One-hundred sixty-seven patients (85% white, 58% female, mean age 60… Expand
Factors influencing cancer genetic somatic mutation test ordering by cancer physician
Cancer patients’ views and understanding of genome sequencing: a qualitative study
Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing
Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Physicians' attitudes about multiplex tumor genomic testing.
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
Cancer genomics and inherited risk.
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
  • M. Robson, A. Bradbury, +7 authors N. Lindor
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2015
Clinical whole-exome sequencing for the diagnosis of mendelian disorders.
...
1
2
3
4
5
...